131 related articles for article (PubMed ID: 9723953)
1. Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat.
Malone DT; Taylor DA
Br J Pharmacol; 1998 Aug; 124(7):1419-24. PubMed ID: 9723953
[TBL] [Abstract][Full Text] [Related]
2. Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats.
Malone DT; Taylor DA
Br J Pharmacol; 1999 Sep; 128(1):21-6. PubMed ID: 10498830
[TBL] [Abstract][Full Text] [Related]
3. Involvement of somatodendritic 5-HT(1A) receptors in Delta(9)-tetrahydrocannabinol-induced hypothermia in the rat.
Malone DT; Taylor DA
Pharmacol Biochem Behav; 2001; 69(3-4):595-601. PubMed ID: 11509221
[TBL] [Abstract][Full Text] [Related]
4. The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at differnt ambient temperatures.
Fennessy MR; Taylor DA
Br J Pharmacol; 1977 May; 60(1):65-71. PubMed ID: 884391
[TBL] [Abstract][Full Text] [Related]
5. Hypothermia induced by delta9-tetrahydrocannabinol in rats with electrolytic lesions of preoptic region.
Schmeling WT; Hosko MJ
Pharmacol Biochem Behav; 1976 Jul; 5(1):79-83. PubMed ID: 996043
[TBL] [Abstract][Full Text] [Related]
6. SR 141716A differentially attenuates the behavioral effects of delta9-THC in rhesus monkeys.
McMahon LR; Amin MR; France CP
Behav Pharmacol; 2005 Sep; 16(5-6):363-72. PubMed ID: 16148440
[TBL] [Abstract][Full Text] [Related]
7. Behavioural effects of co-administration of delta9-tetrahydrocannabinol with fluoxetine in rats.
Goddard M; Smith PF; Ashton JC
Pharmacology; 2010; 86(2):125-8. PubMed ID: 20689343
[TBL] [Abstract][Full Text] [Related]
8. Explication of CB
Nguyen JD; Creehan KM; Grant Y; Vandewater SA; Kerr TM; Taffe MA
Drug Alcohol Depend; 2020 Sep; 214():108166. PubMed ID: 32717503
[TBL] [Abstract][Full Text] [Related]
9. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
[TBL] [Abstract][Full Text] [Related]
10. JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects.
Rodriguez JS; McMahon LR
Eur J Pharmacol; 2014 Oct; 740():151-9. PubMed ID: 24972243
[TBL] [Abstract][Full Text] [Related]
11. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
12. Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva).
Darmani NA; Crim JL
Pharmacol Biochem Behav; 2005 Jan; 80(1):35-44. PubMed ID: 15652378
[TBL] [Abstract][Full Text] [Related]
13. 5-HT reuptake and 5-HT2 receptors modulate capsaicin-evoked hypothermia in rats.
Ding Z; Cowan A; Rawls SM
Neurosci Lett; 2008 Jan; 430(3):191-6. PubMed ID: 18155835
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of the effects on thermoregulation of delta9-tetrahydrocannabinol by clomipramine in the rat.
Fennessy MR; Taylor DA
Br J Pharmacol; 1978 Jun; 63(2):267-73. PubMed ID: 667419
[TBL] [Abstract][Full Text] [Related]
15. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
Järbe TU; DiPatrizio NV
Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
[TBL] [Abstract][Full Text] [Related]
16. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
[TBL] [Abstract][Full Text] [Related]
17. Profound hypothermia in mammals treated with tetrahydrocannabinols, morphine, or chlorpromazine.
Haavik CO
Fed Proc; 1977 Nov; 36(12):2595-8. PubMed ID: 913617
[TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
McMahon LR
Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
[TBL] [Abstract][Full Text] [Related]
19. Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat.
Taylor DA; Fennessy MR
Eur J Pharmacol; 1977 Nov; 46(2):93-9. PubMed ID: 590330
[TBL] [Abstract][Full Text] [Related]
20. Relationship between body temperature and brain monoamines during the development of tolerance to delat9-tetrahydrocannabinol in the rat.
Taylor DA; Fennessy MR
Psychopharmacology (Berl); 1978 Apr; 56(3):279-85. PubMed ID: 418435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
